Bell Investment Advisors’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $695 | Buy |
74
+61
| +469% | +$573 | ﹤0.01% | 1685 |
|
|
2025
Q1 | $93 | Hold |
13
| – | – | ﹤0.01% | 1887 |
|
|
2024
Q4 | $152 | Hold |
13
| – | – | ﹤0.01% | 1881 |
|
|
2024
Q3 | $268 | Sell |
13
-41
| -76% | -$845 | ﹤0.01% | 1846 |
|
|
2024
Q2 | $1.21K | Hold |
54
| – | – | ﹤0.01% | 1552 |
|
|
2024
Q1 | $1.49K | Buy |
54
+20
| +59% | +$550 | ﹤0.01% | 1466 |
|
|
2023
Q4 | $1.04K | Sell |
34
-5
| -13% | -$153 | ﹤0.01% | 1583 |
|
|
2023
Q3 | $1.23K | Buy |
39
+26
| +200% | +$823 | ﹤0.01% | 1485 |
|
|
2023
Q2 | $531 | Sell |
13
-42
| -76% | -$1.72K | ﹤0.01% | 1824 |
|
|
2023
Q1 | $2.05K | Buy |
55
+27
| +96% | +$1.01K | ﹤0.01% | 1253 |
|
|
2022
Q4 | $977 | Buy |
28
+17
| +155% | +$593 | ﹤0.01% | 1606 |
|
|
2022
Q3 | $1K | Hold |
11
| – | – | ﹤0.01% | 1498 |
|
|
2022
Q2 | $1K | Buy |
+11
| New | +$1K | ﹤0.01% | 1518 |
|
|
2021
Q4 | $0 | Hold |
4
| – | – | ﹤0.01% | 1896 |
|
|
2021
Q3 | $1K | Buy |
+4
| New | +$1K | ﹤0.01% | 1485 |
|